Fameco Surplus Solutions
Industry
Healthcare
Investment Year
2024
Equity stake
2,4%
Headquarters
Woonsocket, Rhode Island
About Fameco Surplus Solutions
Surplus Solutions specialises in the procurement, resale, and auctioning of clinical laboratory and processing equipment for the biotech, pharmaceutical, and life sciences sectors. By extending the lifecycle of high-quality equipment, the company helps businesses optimise resources while promoting sustainability and cost-efficiency.
Following the sale of Fameco Group in 2024, Unity Group has reinvested in Surplus Solutions, as Fameco is now part of the company.
Unity Group remains committed to promoting innovation and operational excellence across its portfolio and is confident that NMS Capital’s expertise will propel Fameco to become a leading international provider of equipment lifecycle services.
